Doctor-guided GLP⁠-⁠1 care for Connecticut

Yes. You complete a short medical intake online, and a doctor licensed in Connecticut personally reviews it — no video visit needed (you can book one if you want it). If treatment is appropriate for you, your prescription is filled by a licensed US pharmacy and shipped overnight to your door anywhere in Connecticut. You don't need to visit a clinic to start treatment.

Our semaglutide program starts at $112/month (once-daily oral drops) or $135/month (weekly injections). Tirzepatide starts at $169/month. The price includes the medication itself, your doctor visits, ongoing medical supervision, and overnight refrigerated shipping. There is no membership fee, and the intake and your doctor's first review or visit are free: you pay nothing until you choose to start medication.

Not at this time. We charge one all-in monthly price with the medication, doctor visits, and shipping included, so there is no prior authorization. HSA and FSA cards are accepted at checkout, and we provide itemized receipts and a Letter of Medical Necessity on request.

Compounded semaglutide (the active ingredient in Wegovy and Ozempic), available as once-daily oral drops or a weekly injection, and compounded tirzepatide (the active ingredient in Zepbound and Mounjaro) as a weekly injection. The injections also contain an added ingredient, such as a B vitamin, that the brand products do not. Your doctor recommends the medication, form, and dose that fit your health history and goals.

James Simmons, MD, our medical director, is licensed in Connecticut and board-certified in emergency medicine (ABEM). He personally reviews your intake, meets with you over video when either of you wants a visit, and supervises your treatment over time.

All of Connecticut. Care is fully online and medication ships overnight statewide, so care is the same whether you're in Bridgeport, New Haven, Stamford, Hartford, or a town without a weight-management clinic nearby.

Not through Gentle Health. We do not bill Medicare, HUSKY Health (Connecticut Medicaid) or private insurance, and everyone pays the prices shown on this page. To pursue coverage instead you would need a provider who accepts your plan and prescribes a medication it covers — the FDA-approved brands, not a compounded preparation. Where each programme stands:

1. HUSKY Health: Not covered for weight loss. Since January 2025 every GLP-1 pharmacy claim has needed a type 2 diabetes diagnosis code, and the approved state plan covers only orlistat and phentermine as weight-loss drugs. Wegovy and Zepbound are reachable only with prior authorization for a different condition: cardiovascular risk reduction, MASH or obstructive sleep apnea.
2. Medicare: Coverage may still be possible through the federal GLP-1 Bridge: a $50 copay for Wegovy, Zepbound or Foundayo through December 31, 2027, for Part D enrollees with a BMI of 35 or more, or lower with specific heart, stroke, artery, blood-pressure, kidney or prediabetes conditions. Type 2 diabetes, moderate-to-severe sleep apnea and MASH are covered through regular Part D instead.

No. Connecticut's telehealth law, § 19a-906, lets a provider deliver care through real-time video or store-and-forward review — an asynchronous transfer of your medical information that the doctor reviews later — and defines telehealth to include both. Its only prescribing limit applies to schedule I, II and III controlled substances, which GLP-1s are not. A separate Connecticut rule, § 20-613a, does bar prescriptions issued solely from an electronic questionnaire without an examination — but the legislature confined that rule to controlled substances too.

Only if you say so. At your first telehealth interaction, § 19a-906(d) requires the provider to ask whether you consent to your telehealth records being shared with your primary care provider. If you do, the records go to them in a timely manner; if you don't, they stay with us. Your consent to telehealth itself is recorded in your health record and you can revoke it at any time.